2. HISTORY
• Age
• Sex
• Socioeconomic strata
• Diet & personal history
• Developmental history
• History pointing towards probable etiology
• Treatment history & compliance
6. RBC COUNT
• Measured by laser light scatter methodology
• In IDA decreased in proportion with MCV
• MCV÷RBC >13
7. MCV
• Mean on histogram of RBC size distribution
• <80fl
8. RDW
• Coefficient of variation or SD of size distribution
• Quantifies degree of anisocytosis
• Normally <15%
• Increase with decrease in IDA & normal in thal & ACD
14. Tr Saturation
• Sr iron÷TIBC
• N Range 20-45%
• <20% suggest IDA
• >45% in Hemochromatosis
15. FERRITIN
• High molecular weight protein consists of 20% iron
• Serves as iron reserve in RE cells & hepatocytes
• Small amount present in serum reflect iron stores
• 45-340ng/dl
• In setting of inflammation value <100 suggest depleted iron stores
• <10 in severe IDA
17. CHr
Realtime snapshot of iron directly available for Hb synthesis
By flow cytometry light scatter
N range (26-32pg)
<26 in iron deficient erythropoiesis
Response to EPO can be assesed
Little affected by inflammation
18. sTfR
Present on external surface of plasma membrane
Iron-transferrin complex binds to receptor
complex internalised & iron released
Proteolytic cleavage releases truncated sTfR
• Inverse relation to iron status
• Not an acute phase reactant
• N range 1.8-4.6 mg/L
19. HEPCIDIN
• Regulator of iron metabolism
• Binds to ferroportin & degrade it leading to decreased iron absorption
& export
• Decrease in IDA
24. IRIDA
• AR
• TMPRSS6 gene on chromosome 22 encoding serine protease
Metriptase2
• Metriptase 2 is a negative regulator of hepcidin
• Mutation leads to decreased activity of metriptase 2 with subsequent
increase in hepcidin which decrease iron absorption